Expression of CXCR3 on mononuclear cells and CXCR3 ligands in patients with metastatic renal cell carcinoma in response to systemic IL-2 therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/17457216

Download in:

View as

General Info

PMID
17457216